Clinical Trial Update: Matched Paired Pharmacodynamics and Feasibility Study of Durvalumab in Combination With Chemotherapy in Frontline Ovarian Cancer (N-Dur) [Phase 1, Phase 2]

View source ↗

Summary

This Phase 1/2 study tests durvalumab in combination with chemotherapy as frontline treatment for ovarian cancer and related gynecologic cancers, focusing on ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• IMFINZI (DURVALUMAB)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Stage III Fallopian Tube Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7 | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING